Table 4. Progression-free survival: indirect comparison of sunitinib vs bevacizumab plus IFN.

Comparison	Input data	HR (95% CI)	P-value
Sunitinib vs IFN	Motzer: HR=0.538; SE[ln(HR)]=0.103	0.538 (0.439, 0.658)	<0.0001*
Bevacizumab vs IFN	{AVOREN: HR=0.630; SE[ln(HR)]=0.093 CALGB: HR=0.710; SE[ln(HR)]=0.079}	0.676 (0.601, 0.760)	<0.0001*
Sunitinib vs bevacizumab	[Indirect comparison]	0.796 (0.630, 1.004)	0.0272*

Abbreviations: HR=hazard ratio; IFN=interferon.

Based on 100 000 MCMC iterations.^*One-tailed P-values.